Improving hospice care transitions for diverse patients with advanced dementia
Official title: Engage-D: DEsigNing Culturally Sensitive Care ManaGement for Hospice TrAnsitions for Diverse Persons LivinG with AdvancEd Dementia
Funded at New York University · NIH-10886204 · Data updated 2026-11-12
This study is looking to make hospice care better for people with advanced Alzheimer's and similar conditions, especially for those from different racial and ethnic backgrounds, by finding out what stops them from getting the help they need and creating supportive solutions that fit their cultural needs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $195,480 |
| NIH project number | 1K23AG083125-01A1 |
| Project ID | NIH-10886204 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older living with advanced Alzheimer's disease or related dementias, particularly from racially and ethnically diverse backgrounds.
✕Less likely to help
Patients who are not living with advanced dementia or those who do not belong to racially or ethnically diverse groups may not benefit from this research.
What this research studies
This research focuses on enhancing hospice care transitions for individuals living with advanced Alzheimer's disease and related dementias, particularly among racially and ethnically diverse populations. It aims to identify and address the barriers that prevent these groups from accessing hospice services, such as cultural beliefs, mistrust, and lack of representation in research. By developing culturally sensitive care management interventions, the project seeks to improve the quality of end-of-life care and reduce hospitalizations for these patients. The approach involves collaboration with home healthcare professionals and caregivers to create effective strategies that can be integrated into existing care models.
Why it matters
Potential benefit: If successful, this research could lead to improved access to hospice care and better end-of-life experiences for diverse patients with advanced dementia.
How similar studies have gone: Previous research has indicated that culturally tailored interventions can improve healthcare access and outcomes for underserved populations, suggesting potential success for this approach.
Where this research is happening
-
New York University
New York, United States Active
Researchers
- Principal investigator: Murali, Komal Patel — New York University
- Study coordinator: Murali, Komal Patel
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Synthetic protein mimetics to treat Lewy Body Dementia
A new therapeutic approach using engineered protein-like molecules to block the harmful protein clumps that cause Lewy Body Dementia.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
New biomarkers to distinguish LATE from Alzheimer’s disease in dementia
A study to develop blood and CSF tests that can tell apart LATE from Alzheimer’s disease in people with dementia.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.